Home › Funds › TENOR CAPITAL MANAGEMENT Co., L.P. › TVTX

TENOR CAPITAL MANAGEMENT Co., L.P. position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

TENOR CAPITAL MANAGEMENT Co., L.P. reported holding 28,000,000 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$33.0M, representing 0.61% of its reported portfolio and ranking #44 among its reported holdings. TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed TVTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)28.00M sh
Reported value held$33.00M
Portfolio Weight0.61%
First reportedQ4 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TENOR CAPITAL MANAGEMENT Co., L.P.'s TVTX position evolved

TENOR CAPITAL MANAGEMENT Co., L.P. first disclosed a stake in TVTX in Q4 2025 at 13,760,000 shares (US$19.7M). The position peaked in Q1 2026 at 32,000,000 shares, worth US$40.4M. Across 4 filings, TENOR CAPITAL MANAGEMENT Co., L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 28,000,000 shares valued at US$33.0M. Notable position changes include a 133% increase in Q1 2026 (shares rose 91% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 13.76M $19.68M New
Q1 2026 32.00M $40.45M Add
Q2 2026 28.00M $32.96M Reduce
Q3 2026 28.00M $33.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$208.6M), Rock Springs Capital Management LP (US$129.8M), Kynam Capital Management, LP (US$117.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has TENOR CAPITAL MANAGEMENT Co., L.P. held TVTX?

TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed TVTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is TENOR CAPITAL MANAGEMENT Co., L.P.'s current position in TVTX?

As of Q3 2026, TENOR CAPITAL MANAGEMENT Co., L.P. holds 28.00M shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $33.00M, representing 0.61% of its reported portfolio and ranking #44.

Has TENOR CAPITAL MANAGEMENT Co., L.P. been buying or selling TVTX?

In the latest 13F filing (Q3 2026), TENOR CAPITAL MANAGEMENT Co., L.P. held unchanged its position in TVTX. The position peaked in Q1 2026 at 32.00M shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.